![]() Amedisys stock price target cut to $135 from $165 at Benchmark Oct. ![]() The stock price of Amedisys (NASDAQ:AMED), a home-health and hospice company, reached its 52-week low of $175 in yesterday’s trading session.AMED stock has seen a gradual decline from levels of.Do the numbers hold clues to what lies ahead for the stock? Amedisys (AMED) delivered earnings and revenue surprises of 28.04% and 2.47%, respectively, for the quarter ended June 2023.AMED: Raising target price to $99.00 AMEDISYS INC has an Investment Rating of HOLD a target price of $99.000000 an Industry Subrating of Medium a Management Subrating of Medium a. What are analysts forecasts for Amedisys stock? The 58 analysts offering price forecasts for Amedisys have a median target of 139.52, with a high estimate of 225.00 and a low estimate of 85.00.View daily, weekly or monthly format back to when Amedisys, Inc. Discover historical prices for AMED stock on Yahoo Finance.Read why we see no change to our thesis and AMED stock is still a Hold. Amedisys’ CEO departed last week, although management reaffirmed FY22 guidance.Swiss National Bank owned approximately 0.22% of Amedisys worth $5,163,000 as. The fund owned 70,200 shares of the health services provider’s stock after selling 8,100 shares during the period.Gerard became CEO after serving as chief operating officer from 2016 to April, when Kusserow resigned. Since the start of 2022, the stock’s value has dropped by nearly 50%, closing Thursday at $84.72 a share. Shares of Amedisys have trended steadily downward since the stock was trading at more than $260 a share in July 2021.North Tide Capital LLC's Amedisys shares are currently valued at $657.78M. North Tide Capital LLC is the largest individual Amedisys shareholder, owning 7.12M shares representing 21.84% of the company. Amedisys ( NASDAQ: AMED) is owned by 91.22% institutional shareholders, 28.93% Amedisys insiders, and 0.00% retail investors. The Home Health segment offers a range of services in the homes of individuals for the. It operates through four segments: Home Health, Hospice, Personal Care, and High Acuity Care. Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. Ashworth is a pharmacist and a highly respected and accomplished healthcare executive with expertise in driving transformational growth, large scale operations management, shaping. Richard Ashworth is the President and Chief Executive Officer for Amedisys, Inc., the leading provider of quality home health, hospice, and high-acuity care services. Amedisys Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. The stock price of Amedisys, a home-health and hospice company, reached its 52-week low of $175 in yesterday’s trading session.AMED stock has seen a gradual decline from levels of over $310 in.Style is calculated by combining value and growth scores, which are. Style is an investment factor that has a meaningful impact on investment risk and returns. The Home Health Segment provides skilled nurses, therapists, and aids to patients' homes throughout the United. ![]() The company brings healthcare to the home through the provision of home healthcare services, hospice services, high acuity care segment, and personal care services. Amedisys Inc is a healthcare services company in the United States. These companies are all part of the "medical" sector. ![]() The main competitors of Amedisys include Chemed (CHE), AdaptHealth (AHCO), Addus HomeCare (ADUS), Option Care Health (OPCH), iRhythm Technologies (IRTC), Privia Health Group (PRVA), Bausch Health Companies (BHC), Blueprint Medicines (BPMC), Indivior (INDV), and Arrowhead Pharmaceuticals (ARWR).Currently, shares of Amedisys are trading at $91.05. In a separate announcement Amedisys said that it has mutually terminated its all-stock merger agreement with Option Care Health Inc.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |